Literature DB >> 8286740

Structural changes in platelet glycoprotein IIb/IIIa by plasmin: determinants and functional consequences.

B Pasche1, H Ouimet, S Francis, J Loscalzo.   

Abstract

Plasmin exposure modulates platelet aggregation responses, but a direct effect of plasmin on the platelet fibrinogen receptor, glycoprotein IIb/IIIa (GPIIb/IIIa), has never been conclusively shown in a plasma milieu. To examine this issue, we incubated platelets in platelet-rich plasma with plasmin and measured the effect of this treatment on platelet aggregation, fibrinogen binding, and the structural integrity of GPIIb/IIIa. Plasmin treatment reduced maximal reversible fibrinogen binding in a dose-dependent fashion, and this reduction in binding was accompanied by a correlative reduction in the maximal rate of aggregation. Immunoblots performed with polyclonal antibodies against GPIIb/IIIa showed that GPIIIa had been cleaved by plasmin, but this cleavage was detected only after subsequent degradation of the solubilized GPIIb/IIIa with Staphylococcus aureus V8 (Glu-C) endoprotease. Peptide sequence analysis showed that cleavage occurred at the lys444-pro445 bond in the first cysteine-rich repeat domain of GPIIIa a unique proteolytic event observed only in the presence of plasma fibrinogen. These observations suggest that plasmin modifies GPIIIa by a unique proteolytic event in plasma that is dependent on fibrinogen binding and, consequently, is accompanied by significant reductions in fibrinogen binding and aggregation response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8286740

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  Antifibrinolytic Therapy and Perioperative Considerations.

Authors:  Jerrold H Levy; Andreas Koster; Quintin J Quinones; Truman J Milling; Nigel S Key
Journal:  Anesthesiology       Date:  2018-03       Impact factor: 7.892

2.  Platelets retain inducible alpha granule secretion by P-selectin expression but exhibit mechanical dysfunction during trauma-induced coagulopathy.

Authors:  Alexander E St John; Jason C Newton; Erika J Martin; Bassem M Mohammed; Daniel Contaifer; Jessica L Saunders; Gretchen M Brophy; Bruce D Spiess; Kevin R Ward; Donald F Brophy; José A López; Nathan J White
Journal:  J Thromb Haemost       Date:  2019-03-18       Impact factor: 5.824

3.  Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide.

Authors:  A Zai; M A Rudd; A W Scribner; J Loscalzo
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 4.  Device-Induced Hemostatic Disorders in Mechanically Assisted Circulation.

Authors:  Shigang Wang; Bartley P Griffith; Zhongjun J Wu
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 5.  Cirrhosis and Coagulopathy: Mechanisms of Hemostasis Changes in Liver Failure and Their Management.

Authors:  Rabia Islam; Sumana Kundu; Surajkumar B Jha; Ana P Rivera; Gabriela Vanessa Flores Monar; Hamza Islam; Sri Madhurima Puttagunta; Ibrahim Sange
Journal:  Cureus       Date:  2022-04-03

6.  Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness.

Authors:  Natasa Obermajer; Bojan Doljak; Janko Kos
Journal:  Mol Cancer       Date:  2009-10-21       Impact factor: 27.401

7.  Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery.

Authors:  Adam Miszta; Homa K Ahmadzia; Naomi L C Luban; Shuhui Li; Dong Guo; Lori A Holle; Jeffrey S Berger; Andra H James; Jogarao V S Gobburu; John van den Anker; Bas de Laat; Alisa S Wolberg
Journal:  J Thromb Haemost       Date:  2020-12-26       Impact factor: 5.824

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.